RECURSION PHARMACEUTICALS, INC. Q2 Loss Decreases
(RTTNews) - RECURSION PHARMACEUTICALS, INC. (RXRX) released Loss for second quarter of -$131.005 million
The company's earnings came in at -$131.005 million, or -$0.25 per share. This compares with -$171.897 million, or -$0.41 per share, last year.
The company's revenue for the period fell 42.0% to $7.670 million from $13.223 million last year.
RECURSION PHARMACEUTICALS, INC. earnings at a glance (GAAP) :
-Earnings: -$131.005 Mln. vs. -$171.897 Mln. last year. -EPS: -$0.25 vs. -$0.41 last year. -Revenue: $7.670 Mln vs. $13.223 Mln last year.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.